Embolex and Haematuria aggravated - a phase IV clinical study of FDA data

Summary:

Haematuria aggravated is reported as a side effect among people who take Embolex (dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Dotarem, and have Blood pressure abnormal.

The phase IV clinical study analyzes which people have Haematuria aggravated when taking Embolex. It is created by eHealthMe based on reports of 1,159 people who have side effects when taking Embolex from the FDA, and is updated regularly.

What is Embolex?

Embolex has active ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride. eHealthMe is studying from 1,161 Embolex users. Check the latest studies of Embolex.

What is Haematuria aggravated?

Haematuria aggravated (presence of blood in urine) is found to be associated with 1,725 drugs and 1,763 conditions by eHealthMe. Check the latest studies of Haematuria aggravated.

On Jul, 11, 2026

1,159 people reported to have side effects when taking Embolex.
Among them, 16 people (1.38%) have Haematuria aggravated.

Could Embolex cause Haematuria aggravated?

Among these 16 people:

How long have people been on Embolex when they have Haematuria aggravated? *

What is the gender of people who have Haematuria aggravated when taking Embolex? *

female: 80 %
male: 20 %

What is the age of people who have Haematuria aggravated when taking Embolex? *

What are other drugs people take besides Embolex? *

What are other side effects people have besides Haematuria aggravated? *

High Blood Pressure: 11 people, 68.75%
Fatigue (feeling of tiredness): 11 people, 68.75%
Weight Increased: 11 people, 68.75%
Heavy Or Prolong Menstrual Bleeding: 11 people, 68.75%
Heart Rate Irregular: 11 people, 68.75%
Heart Rate Increased: 11 people, 68.75%
Haematoma (collection of blood outside the blood vessels): 11 people, 68.75%
Haematocrit Decreased: 11 people, 68.75%
Glomerulonephritis Chronic (long lasting group of conditions that affect parts of the kidneys called glomeruli): 11 people, 68.75%
General Physical Health Deterioration (weak health status): 11 people, 68.75%

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 11 people, 68.75%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 11 people, 68.75%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11 people, 68.75%
Blood Pressure Abnormal: 11 people, 68.75%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 18.75%
Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Embolex and have Haematuria aggravated?

- Check whether Haematuria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Embolex:

Embolex (1,161 reports)

Haematuria aggravated treatments and more:

Haematuria aggravated (3 reports)

How severe was Haematuria aggravated and when was it recovered:

Haematuria aggravated in Embolex

Expand to all the drugs that have ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride:

Haematuria aggravated and drugs with ingredients of dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (16 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Embolex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haematuria aggravated:

Haematuria aggravated (1,725 drugs)

Browse all the conditions that are associated with Haematuria aggravated:

Haematuria aggravated (1,763 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dihydroergotamine mesylate; heparin sodium; lidocaine hydrochloride (the active ingredients of Embolex) and Embolex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.